The Relation of CFTR-Genotype and Associated Comorbidities to Development of Pulmonary Atelectasis in Cystic Fibrosis Patients
Arch Bronconeumol. 2022 Sep;58(9):666-668.
doi: 10.1016/j.arbres.2022.02.009.
Epub 2022 Mar 11.
[Article in
English,
Spanish]
Authors
M Martínez-Redondo
1
, C Prados Sánchez
2
, F García-Rio
1
, E Quintana Gallego
3
, S Castillo Corullón
4
, A Salcedo Posadas
5
, R Girón Moreno
6
, M T Martínez Martínez
7
, L Máiz Carro
8
, C Martin de Vicente
9
, J Costa Colomer
10
, R Álvarez-Sala Walther
1
; Spanish Working Group Atelectasis in CF
Affiliations
- 1 Cystic Fibrosis Unit, Department of Pulmonology, La Paz University Hospital, Madrid, Spain.
- 2 Cystic Fibrosis Unit, Department of Pulmonology, La Paz University Hospital, Madrid, Spain. Electronic address: conchaprados@gmail.com.
- 3 Cystic Fibrosis Unit, Department of Pulmonology, Virgen del Rocio University Hospital, Sevilla, Spain.
- 4 Cystic Fibrosis Unit, Department of Pediatrics, Clinic Hospital, Valencia, Spain.
- 5 Cystic Fibrosis Unit, Department of Pediatrics, Niño Jesus Hospital, Madrid, Spain.
- 6 Cystic Fibrosis Unit, Department of Pulmonology, La Princesa University Hospital, Madrid, Spain.
- 7 Cystic Fibrosis Unit, Department of Pulmonology, Doce de Octubre University Hospital, Madrid, Spain.
- 8 Cystic Fibrosis Unit, Department of Pulmonology, Ramón y Cajal University Hospital, Madrid, Spain.
- 9 Cystic Fibrosis Unit, Department of Pediatrics, Miguel Servet Hospital, Zaragoza, Spain.
- 10 Cystic Fibrosis Unit, Department of Pediatrics, Sant Joan de Dêu, Barcelona, Spain.
No abstract available
MeSH terms
-
Cystic Fibrosis Transmembrane Conductance Regulator / genetics
-
Cystic Fibrosis* / complications
-
Cystic Fibrosis* / genetics
-
Genotype
-
Humans
-
Mutation
-
Pulmonary Atelectasis* / genetics
Substances
-
CFTR protein, human
-
Cystic Fibrosis Transmembrane Conductance Regulator